newsfilter
← Latest News
PR Newswire·

Khiron Life Sciences Reports Third Quarter 2022 Financial Results

In Europe, revenues increased by 141% year-over-year, driven by revenues in the United Kingdom, where the Corporation is now increasing its existing product portfolio, and the specialized cannabis clinic Zerenia™